Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized study of palifermin for prevention of mucositis after allogeneic stem cell transplantation with myeloablative total body irradiation
2006-003683-54Phase 2Completed
- Sponsor
- GMIHO
- Start
- May 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of palifermin in Acute Leukaemia, B-cell chronic lymphocytic leukemia (B-CLL) and stomatitis (2 arms), sponsored by GMIHO. Primary endpoint: Incidence of severe oral mucositis. Started May 2008; status: completed.
02
Drugs
palifermin
03
Conditions
Acute LeukaemiaB-cell chronic lymphocytic leukemia (B-CLL)stomatitis
Beyond the preview
Go deeper on 2006-003683-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003683-54.